AYA cancer survivors have a higher cancer risk compared to the general population for most cancers up to 25 years after their initial cancer diagnosis. Additional studies that investigate risk factors for the specific cancer type combinations are needed to develop personalized follow-up strategies.

Late Effects of TreatmentAllArticle
Long-Term Second Primary Cancer Risk in Adolescent and Young Adult (15-39 Years) Cancer Survivors: A Population-Based Study in the Netherlands Between 1989 and 2018
Few studies have comprehensively investigated the long-term second cancer risk among adolescent and young adult (AYA, aged 15-39 years) cancer survivors. This study investigated the long-term second cancer risk by including the full range of first and second cancer combinations with at least 10 observations in the Netherlands between 1989 and 2018.
Written byPOLA Editorial Team
Published:
Related Resources

Questionnaire And Linkage-Based Outcomes in Dutch Childhood Cancer Survivors: Methodology of the Dccss Later Study Part 1
The Dutch Childhood Cancer Survivor Study LATER cohort (1963-2001) focuses on long-term health outcomes in childhood can...
Late Effects of TreatmentAll
Read

Long-Term Side Effects of Cancer Treatment: What Survivors Need to Know
Discover the long-term side effects of cancer treatment, from physical challenges like fatigue, heart health issues, and...
Late Effects of TreatmentAll
Read

Endocrine Late Effects in Childhood Cancer Survivors
Recent advances in cancer treatment have led to improved survival, with an exponential increase in sequelae among surviv...
Late Effects of TreatmentAll
Read
